PUBLIC COMPANY
save$CPIXCUMBERLAND PHARMACEUTICALS INC
$CPIX7.7900-0.13%Nashville,, TN, USupdated 17h ago
community read0 votes
🐶 often sniffed alongside
top 5pipeline
5
marketed
4
phase 3
0
catalysts ytd
8
approvals ytd
2
recalls ytd
0
Pipeline(5)
pipeline depth5 products
1Phase 24Marketed
Upcoming
Recent(90d)
earnings (1)
Active trials
- phase2Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
- phase2Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
- phase2Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- phase2Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
- phase1Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)
- phase4Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
- phase4Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 18, 26grantKAZIMI A J · Chairman and CEO100,000 sh
- Mar 18, 26grantKrogulski Kenneth · 4,000 sh
- Mar 18, 26grantAnthony Todd M. · Vice Pres Organizational Dev3,000 sh
- Mar 18, 26grantBitterman Chris T. · Vice Pres Sales & Marketing3,000 sh
- Mar 18, 26grantHamm John M. · VP Chief Financial Officer3,000 sh
- Mar 18, 26grantHerman James L · VP and Chief Compliance Office2,500 sh
🐶 Hiring Signal
next earnings Nov 3, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 17m ago
Found something off?
comments(0)
5-min edit window · permanent after that